Hims & Hers Announces Planned 2026 Expansion To Canada, Following ZAVA Acquisition Completion

Hims & Hers Health, Inc., a digital health and wellness platform, announced plans to bring its affordable, holistic weight loss program to Canada, timed with the anticipated first-ever availability of generic semaglutide anywhere in the world. This move follows the recent closing of the company's acquisition of ZAVA, a digital health platform in Europe, the announcement said. Financial terms of the acquisition were not disclosed in the announcement.

Almost two-thirds of adults in Canada are overweight or living with obesity, yet access to proven treatments remains limited due to high costs and availability, according to the announcement . . .